Skip to content

Venovo Venous Stent System

by Bard Peripheral Vascular, Inc. PMA

Active United States

PMA P180037

Overview

The Venovo Venous Stent System is a Stent, Iliac Vein (Class III device), designed to treat symptomatic iliofemoral venous outflow obstruction. This endovascular device is intended for percutaneous placement within the iliac veins to restore venous flow and alleviate obstruction-related symptoms, such as swelling, pain, or venous ulcers.

The system is supplied sterile and intended for single-use. It is regulated under FDA_PMA (P180037) and requires professional medical supervision for deployment via fluoroscopic guidance. Stent sizes and configurations are tailored for iliac vein placement, with multiple reference codes (e.g., 3002807314, 3009526575) corresponding to specific diameters and lengths. Storage and handling must comply with sterile medical device protocols.

AI-generated from registry data, 18 Sep 2026.Not verified by deviCERTS or the manufacturer

Regulatory status

as of 28 Oct 2026

Recall ongoing. 3 ongoing FDA recalls. See recalls

RegionAuthorizationNumberDateStatus
United StatesFDA PMAAPPR Approved NumberP180037 Date13 Mar 2019ApprovedStatusActive

Coverage

1 jurisdiction

United States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not known
  • Not covered

United States — FDA PMA Active

Recalls

3 recalls · 3 ongoing · FDA

  • 3 recalls, same reason

    • Ongoing Z-1897-2021 FDA Class II initiated 14 Dec 2020
    • Ongoing Z-1899-2021 FDA Class II initiated 14 Dec 2020
    • Ongoing Z-1898-2021 FDA Class II initiated 14 Dec 2020

    Reports of the proximal end of the stent not immediately expanding upon deployment and remaining connected to the delivery system.

Specification

PMA

Generic Name
Stent, iliac vein
PMA Number
FDA Product Code
QAN
Device Class
Class III
Advisory Committee
Cardiovascular
FDA Decision
APPR Approved

Other devices from Bard Peripheral Vascular, Inc.

See all devices from Bard Peripheral Vascular, Inc. →

Questions

  • What specific venous obstructions does the Venovo Venous Stent System address, and how does it help relieve symptoms?

    The Venovo Venous Stent System is designed to treat symptomatic iliofemoral venous outflow obstruction, which refers to blockages in the iliac veins (the large veins carrying blood from the legs back to the heart). By placing the stent percutaneously within these veins, it restores proper blood flow and alleviates common symptoms like leg swelling, chronic pain, or venous ulcers caused by the obstruction.

  • Is the Venovo Venous Stent System intended for reuse, or is it meant to be used once and then discarded?

    The Venovo Venous Stent System is explicitly labeled as intended for **single-use only**. This means it should not be reused after deployment, as reuse could compromise sterility and device integrity, potentially leading to complications.

  • What sizes and configurations are available for the Venovo Venous Stent System, and how do I identify them?

    The Venovo Venous Stent System comes in multiple sizes and configurations tailored for iliac vein placement. Each variant is associated with a unique **FEI number** (e.g., 3002807314, 3009526575), which corresponds to specific diameters and lengths. These codes help clinicians select the appropriate stent for the patient’s anatomy.

  • How should the Venovo Venous Stent System be stored to maintain its sterility and functionality?

    Since the Venovo Venous Stent System is supplied **sterile**, it must be stored and handled according to standard sterile medical device protocols. This includes keeping it in its original packaging, protecting it from contamination, and adhering to manufacturer guidelines to preserve its integrity before use.

  • What type of professional expertise is required to deploy the Venovo Venous Stent System?

    The Venovo Venous Stent System requires **professional medical supervision** for deployment. It is placed via **fluoroscopic guidance**, meaning an experienced interventional radiologist or vascular specialist should perform the procedure to ensure proper positioning and minimize risks.